Estimation of HTLV-1 vertical transmission cases in Brazil per annum
- PMID: 30418973
- PMCID: PMC6261628
- DOI: 10.1371/journal.pntd.0006913
Estimation of HTLV-1 vertical transmission cases in Brazil per annum
Abstract
Background: Brazil has at least 800,000 HTLV-1 infected individuals. HTLV-1 can be transmitted via sexual intercourse, contact with blood and from mother to child, mainly by breastfeeding. Treatments for the high morbidity/mortality associated diseases (ATL and HAM/TSP) are limited, therefore, infection prevention is of utmost importance. However, antenatal screening is not routinely performed in Brazil. A lack of data regarding the number of individuals infected via breastfeeding impairs the development of government policies. The objective is to estimate the number of HTLV-1 infections occurring annually due to mother to child transmission (MTCT) in Brazil, nationally and regionally.
Methodology: To estimate HTLV-1 MTCT in Brazil the following variables are modelled: number of births, prevalence of HTLV-1 infection in pregnant women, breastfeeding duration rate and transmission risk according to breastfeeding period. The number of cases of HAM/TSP and ATL attributable to MTCT are also estimated.
Principal findings: In 2008, there were 2,934,828 live births in Brazil. HTLV prevalence in pregnant women in Brazil ranges between 0.1-1.05% by region. An estimated 16,548 HTLV-1 infected women are pregnant each year. According to the breastfeeding pattern and HTLV-1 prevalence of each region there are an estimated 3,024 new cases of HTLV-1 infection due to MTCT annually of which 2,610 are preventable through infant feeding advice. These 3,024 transmissions will result in 120-604 cases of ATL and 8-272 of HAM/TSP. North-East region comprises the high number of MTCT cases, followed by South-East.
Conclusions/significance: A high number of new HTLV-1 infections due to MTCT occur every year in Brazil. Antenatal screening and avoiding breastfeeding are essential to prevent subsequent development of HTLV-1-associated diseases.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



References
-
- Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol. 2012;3: 388 10.3389/fmicb.2012.00388 - DOI - PMC - PubMed
-
- Nose H, Saito M, Usuku K, Sabouri AH, Matsuzaki T, Kubota R, et al. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and proviru. J Neurovirol. 2006;12: 171–7. 10.1080/13550280600827336 - DOI - PubMed
-
- Castro-Costa CM, Araújo AQC, Barreto MM, Takayanagui OM, Sohler MP, da Silva ELM, et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses. 2006;22: 931–5. 10.1089/aid.2006.22.931 - DOI - PubMed
-
- Ishihara K, Inokuchi N, Tsushima Y, Tsuruda K, Morinaga Y, Hasegawa H, et al. Relevance of molecular tests for HTLV-1 infection as confirmatory tests after the first sero-screening. J Immunoassay Immunochem. 2014;35: 74–82. 10.1080/15321819.2013.792832 - DOI - PubMed
-
- Santos FLN, Lima FWDM. Epidemiologia, fisiopatogenia e diagnóstico laboratorial da infecção pelo HTLV-I Epidemiology, physiopathogenesis and laboratorial diagnosis of the HTLV-I infection. J Bras Patol Med Lab. 2005;41: 105–116.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous